Fondaparinux as monotherapy for deep vein thrombosis and/or pulmonary embolism (pilot study)

Trial Profile

Fondaparinux as monotherapy for deep vein thrombosis and/or pulmonary embolism (pilot study)

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2007

At a glance

  • Drugs Fondaparinux sodium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top